Lymphoma, T-Cell, Peripheral

Displaying 1 - 2 of 2CSV
Wang, W., Zhang, W., Su, L., Liu, L., Gao, Y., Wang, Q., Su, H., Song, Y., Zhang, H., Shen, J., Jing, H., Wang, S., Cen, X., Liu, H., Liu, A., Li, Z., Luo, J., He, J., Wang, J., … Zhou, D. (2024). Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China. Annals of Hematology, 103(8), 3061–3069. https://doi.org/10.1007/s00277-024-05708-w
Publication Date
Ruan, J., Zain, J., Palmer, B., Jovanovic, B., Mi, X., Swaroop, A., Winter, J. N., Gordon, L. I., Karmali, R., Moreira, J., Petrich, A. M., & Pro, B. (2023). Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma. Blood Advances, 7(19), 5771–5779. https://doi.org/10.1182/bloodadvances.2023009767
Publication Date